ClinicalTrials.gg
Not yet recruitingNCT06779305IMPACTUpdated Jan 16, 2025

Minimally Invasive Procedure Versus Conservative Treatment in the Management of Calcaneal Joint Fractures

An interventional study of Minimally invasive surgical application of Calcanail® and Immobilisation by cast boot in Calcaneus ; Fracture ; Traumatology, sponsored by Centre Hospitalier Universitaire de Nice. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-16.

Sponsored by Centre Hospitalier Universitaire de Nice · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Calcaneal fractures, which affect the heel bone, are the most common type of tarsal fractures and often occur in young people, leading to long recovery times and significant social and economic consequences. Traditional treatments include either non-surgical methods, like immobilizing the foot in a cast, or open surgery, which involves a large incision to fix the bone with plates. However, open surgery has a high complication rate, including issues with wound healing. Recent advances have introduced minimally invasive surgical techniques, which use smaller incisions and have shown better results with fewer complications. This study aims to compare two treatment options for displaced calcaneal fractures: a minimally invasive surgery group and a non-surgical treatment group using a plaster boot. The goal is to determine whether minimally invasive surgery provides better outcomes for patients, such as faster recovery, fewer complications, and improved long-term function, to guide future treatment practices. Thus, this is a prospective, randomised comparative study of the management of articular fractures of the calcaneus: conservative treatment versus minimally invasive surgery.

02

Conditions studied

  • Calcaneus ; Fracture ; Traumatology

Browse trials for

03

In context

Fractures, Bone

2,272 studies on the registry are indexed under Fractures, Bone; 321 are open to participants now.

This study's planned enrollment of 50 is below the median of 68 across 1,490 interventional studies indexed under Fractures, Bone.

Browse Fractures, Bone studies →

Lead sponsor

Centre Hospitalier Universitaire de Nice is the lead sponsor of 722 studies on the registry; 176 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patient aged 18 or over
  2. Patient with a posterior articular fracture of the calcaneus Sanders II to IV, less than 15 days old
  3. Patient affiliated to a social security scheme,
  4. Patient having given written consent following written and oral information.

Exclusion criteria

Exclusion Criteria:

  1. Patient with open calcaneal fracture
  2. Patient with bilateral calcaneal fracture
  3. Patient with extreme varus or valgus impingement of the fibula
  4. Patient with associated talar, tibial, femoral and/or pelvic fracture or associated spinal cord injury.
  5. Patient unsuitable for loco-regional anaesthesia (LRA).
  6. Patient with neuro-psychiatric disorders resulting in an inability to follow a post-surgical or post-immobilisation rehabilitation protocol.
  7. Pregnant women
  8. Patient protected by law under guardianship or curatorship, or unable to participate in a clinical study under article L. 1121-16 of the French Public Health Code.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Minimally invasive surgery group

    Procedure: Minimally invasive surgical application of Calcanail®

  • Active comparator
    Conservative treatment group

    Procedure: Immobilisation by cast boot

Interventions

  • ProcedureMinimally invasive surgical application of Calcanail®

    The procedure involves making small incisions to insert a specialized nail into the bone to realign and stabilize the fracture. This approach minimizes damage to surrounding tissues, reduces the risk of wound complications, and allows for quicker recovery compared to traditional open surgery. after surgery, the patient will benefit from an immobilisation with a plaster boot without support for 3 weeks, followed by immobilisation with a removable walking boot for 3 weeks with partial support depending on the patient's pain.

  • ProcedureImmobilisation by cast boot

    The patient will be immobilised in a plaster cast without support for 3 weeks, followed by immobilisation in a removable walking boot for 3 weeks with partial support depending on the pain.

06

What researchers measure

Primary outcomes

  1. To show a significant difference in favour of minimally invasive surgical treatment compared with orthopaedic treatment for displaced articular fractures of the calcaneus.

    The primary endpoint is the American Orthopaedic Foot \& Ankle Society (AOFAS) clinical score

    Time frame: 1 year follow-up

Secondary outcomes

  1. Demonstrate the superiority of minimally invasive surgical treatment over orthopaedic treatment on :A reduction in the rate of early complications (skin problems, infections, complex regional pain syndrome)

    The superiority of minimally invasive surgery over orthopaedic surgery in terms of early complications will be assessed by the rate of scar disunions, skin necrosis, complex regional pain syndrome (CRPS) and surgical site infections.

    Time frame: 1 year follow-up

  2. Demonstrate the superiority of minimally invasive surgical treatment over orthopaedic treatment on :A reduction in the rate of late complications (rate of arthrodesis revision)

    Assessment of the superiority of minimally invasive surgical treatment over orthopaedic treatment in terms of late complications will be based on the long-term need for revision surgery or subtalar arthrodesis.

    Time frame: 1 year follow-up

  3. Demonstrate the superiority of minimally invasive surgical treatment over orthopaedic treatment on :Improved anatomical relationships (radiological measurements)

    Assessment of the superiority of minimally invasive surgical treatment over orthopaedic treatment in terms of restoration of calcaneal anatomy will be based on radiological measurements: Bohler angle and Meary angle. The Böhler angle is expressed in degrees and correlates with the recovery or otherwise of the calcaneal morphology. The Meary angle is expressed in degrees and correlates with the recovery or otherwise of the axis of the hindfoot.

    Time frame: 1 year follow-up

  4. Demonstrate the superiority of minimally invasive surgical treatment over orthopaedic treatment on : Improved bootability at 1 year.

    Assessment of the superiority of minimally invasive surgical treatment over orthopaedic treatment with respect to footwear will be assessed by being able to fit into: a) all types of footwear, b) some or c) not being able to fit into footwear.

    Time frame: 1 year follow-up

  5. Demonstrate the superiority of minimally invasive surgical treatment over orthopaedic treatment on :A reduction in the time taken to return to work and sport at 1 year.

    Assessment of the superiority of minimally invasive surgical treatment compared to orthopaedic treatment in terms of whether or not the patient can return to work and sport (binary yes or no answer) at follow-up consultations.

    Time frame: 1 year follow-up

  6. Demonstrate the superiority of minimally invasive surgical treatment over orthopaedic treatment on : An improvement in the patient self-assessment score (SAV) at 1 year.

    Assessment of the superiority of minimally invasive surgical treatment compared to orthopaedic treatment in terms of patient self-evaluation score. This will be based on the SAV Simple Ankle Value (PROMS) score (Appendix II). The assessment question will be "What percentage would you rate the function of your ankle today, if 100% was a normal ankle?". The answer will be on a scale from 0% to 100%, where 100% is normal function.

    Time frame: 1 year follow-up

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06779305
Responsible party
Sponsor
First posted
Jan 16, 2025
Start date
Jan 16, 2025 (estimated)
Primary completion
Jan 16, 2028 (estimated)
Completion
Jan 16, 2028 (estimated)
Last update
Jan 16, 2025

Study contacts

Tristan FAUCHILLE, Doctor
Contact
recherche.iuls@chu-nice.fr
0492037524 ext. +33
Charlotte CIAIS
Contact
ciais.c3@chu-nice.fr
0492039393 ext. +33

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion